HIGHLIGHTS
- who: Armin Attar from the Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran have published the article: Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial, in the Journal: (JOURNAL)
- what: This study is conducted to compare single vs. double injection of MSCs. According to recommendations, this trial has been registered with a public registry IRCT.ir.
- how: The trial by including the selected patients who are young and have developed with a reduced LVEF after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.